glp-1 obesity drug news today oct 2025 1 in 10 Americans Has Used Drugs For Weight Loss, Survey Says MedNews Alarming rise in weight loss

In light of increasing rates of both obesity and overweight in the United States, todays approval addresses an unmet medical need. Approximately 70% of Americans are overweight or obese, according to the FDA, and a worrying report published by the World Obesity Federation this year projected that more than half of the worlds population could be overweight or obese by 2035

Nawarskas JJ

Most side effects are mild and temporary, especially when the peptide is used under medical supervision

Consider working with suppliers who partner with GLP-compliant laboratories for higher assurance of consistency

A: Yes, and it is widely preferred over native IGF-1 for this purpose due to its reduced IGFBP binding and sustained receptor stimulation

Meanwhile, Zepbound also faces legal scrutiny because of the complications it is causing consumers